Novartis AG Pre-Tax Income 2010-2024 | NVS

Novartis AG pre-tax income for the twelve months ending June 30, 2024 was $10.899B, a 42.28% increase year-over-year.

  • Novartis AG annual pre-tax income for 2023 was $9.123B, a 27.11% increase from 2022.
  • Novartis AG annual pre-tax income for 2022 was $7.177B, a 72.54% decline from 2021.
  • Novartis AG annual pre-tax income for 2021 was $26.137B, a 164.6% increase from 2020.

Novartis AG Pre-Tax Income 2010-2024 | NVS

  • Novartis AG annual pre-tax income for 2023 was $9.123B, a 27.11% increase from 2022.
  • Novartis AG annual pre-tax income for 2022 was $7.177B, a 72.54% decline from 2021.
  • Novartis AG annual pre-tax income for 2021 was $26.137B, a 164.6% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B